Floatz logo

Sodium Thiosulfate

Neoadjuvant Chemotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySmall moleculePhase 2Dormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Neoadjuvant Chemotherapy cohort.

Asset / SponsorPhaseRating
Epirubicin
Zhejiang Provincial People's Hospital
Phase 3BB
Deoxyadrenaline
Fujian Medical University Union Hospital
Phase 4BB
S-1
Zhejiang Provincial People's Hospital
Phase 2CCC
FLUOROURACILUM
West China Hospital
Phase 2CCC
Adebellizumab
Zhejiang University
Phase 2CCC
Bemotuzumab
Zhejiang Provincial People's Hospital
N/AD

Same molecule, other indications

Sodium Thiosulfate is also rated in:

central nervous system neoplasmDormant
BB
Indicative ·
70 / 100
View asset →
sarcomaDormant
BB
Indicative ·
65 / 100
View asset →
Epithelial Ovarian CancerDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →